Functional Elements in Alpha Crystallin Chaperone

Alpha Crystallin Chaperone 中的功能元素

基本信息

  • 批准号:
    6726181
  • 负责人:
  • 金额:
    $ 25.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-02-01 至 2006-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cataract is a major cause of blindness in the world. A majority of the cataracts develop due to the age-related modifications and aggregation of the eye lens proteins. Alpha-crystallin accounts for nearly 40 percent of the adult lens proteins. In spite of the intense investigations of the past, the structure-function of alpha-crystallin is not fully understood. Nearly a decade ago the chaperone-like activity of alpha-crystallin was discovered but we are yet to fully understand the molecular mechanism of chaperone activity. There is also growing evidence supporting the interaction of beta- and gamma-crystallins with alpha-crystallin in aging lenses and this interaction has been attributed in part to the chaperone activity of alpha-crystallin. Understanding the alpha-crystallin structure and the molecular mechanism of its chaperone action will enable us to define the mechanisms of cataractogenesis and devise methods to delay/stop the process. The overall goal of our research is to get an insight to alpha-crystallin structure-function and understand the molecular mechanism of lens protein aggregation. We have been investigating the properties of alpha-crystallin for some time. During the next five years we propose to 1) dertermine the subunit recognition sites in alphaA- and alphaB-crystallins using a synthetic approach where a series of consecutive overlapping peptides encompassing alphaA- and alphaB-crystallins will be tested for recognition sequences, 2) continue the studies to fully characterize the chaperone-sites in both alphaA- and alphaB-crystallins and 3) investigate the role of alpha-crystallin chaperone activity in the aggregation of lens crystallins.
说明(由申请人提供):白内障是失明的主要原因之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KRISHNA K SHARMA其他文献

KRISHNA K SHARMA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KRISHNA K SHARMA', 18)}}的其他基金

Metastable Crystallins: Structure and Stabilization
亚稳态晶体蛋白:结构和稳定性
  • 批准号:
    8470982
  • 财政年份:
    2013
  • 资助金额:
    $ 25.38万
  • 项目类别:
Metastable Crystallins: Structure and Stabilization
亚稳态晶体蛋白:结构和稳定性
  • 批准号:
    9132472
  • 财政年份:
    2013
  • 资助金额:
    $ 25.38万
  • 项目类别:
Metastable Crystallins: Structure and Stabilization
亚稳态晶体蛋白:结构和稳定性
  • 批准号:
    10200048
  • 财政年份:
    2013
  • 资助金额:
    $ 25.38万
  • 项目类别:
Metastable Crystallins: Structure and Stabilization
亚稳态晶体蛋白:结构和稳定性
  • 批准号:
    8841373
  • 财政年份:
    2013
  • 资助金额:
    $ 25.38万
  • 项目类别:
Metastable Crystallins: Structure and Stabilization
亚稳态晶体蛋白:结构和稳定性
  • 批准号:
    10657220
  • 财政年份:
    2013
  • 资助金额:
    $ 25.38万
  • 项目类别:
Metastable Crystallins: Structure and Stabilization
亚稳态晶体蛋白:结构和稳定性
  • 批准号:
    9265858
  • 财政年份:
    2013
  • 资助金额:
    $ 25.38万
  • 项目类别:
Metastable Crystallins: Structure and Stabilization
亚稳态晶体蛋白:结构和稳定性
  • 批准号:
    8657443
  • 财政年份:
    2013
  • 资助金额:
    $ 25.38万
  • 项目类别:
Metastable Crystallins: Structure and Stabilization
亚稳态晶体蛋白:结构和稳定性
  • 批准号:
    9769023
  • 财政年份:
    2013
  • 资助金额:
    $ 25.38万
  • 项目类别:
Crystallin-Derived Anti-Chaperones in the Lens
晶状体中的晶状体蛋白衍生的反伴侣分子
  • 批准号:
    8306862
  • 财政年份:
    2010
  • 资助金额:
    $ 25.38万
  • 项目类别:
Crystallin-Derived Mini-Chaperones as Protein Aggregation Inhibitors
晶状体蛋白衍生的微型伴侣作为蛋白质聚集抑制剂
  • 批准号:
    7976444
  • 财政年份:
    2010
  • 资助金额:
    $ 25.38万
  • 项目类别:

相似国自然基金

α-crystallins 抑制细胞凋亡和白内障形成的分子机制
  • 批准号:
    81770910
  • 批准年份:
    2017
  • 资助金额:
    56.0 万元
  • 项目类别:
    面上项目

相似海外基金

Mechanisms of structural plasticity, client interactions, and co-aggregation of the lens ⍺-crystallins
晶状体α-晶状体的结构可塑性、客户相互作用和共聚集机制
  • 批准号:
    10709482
  • 财政年份:
    2023
  • 资助金额:
    $ 25.38万
  • 项目类别:
Role of the S100 Family of Proteins in Lens Physiology and Cataract
S100 蛋白家族在晶状体生理学和白内障中的作用
  • 批准号:
    10560827
  • 财政年份:
    2023
  • 资助金额:
    $ 25.38万
  • 项目类别:
Mechanistic Insights and Therapeutic Potential of the Glutaredoxin (Grx) System in the Lens
晶状体中谷氧还蛋白 (Grx) 系统的机理见解和治疗潜力
  • 批准号:
    10592813
  • 财政年份:
    2023
  • 资助金额:
    $ 25.38万
  • 项目类别:
Probing the specific interactions of AlphaA- crystallin and its aging- and cataract-associated forms with lens cell membrane mimics
探讨 AlphaA-晶状体蛋白及其与衰老和白内障相关的形式与晶状体细胞膜模拟物的特定相互作用
  • 批准号:
    10667060
  • 财政年份:
    2023
  • 资助金额:
    $ 25.38万
  • 项目类别:
Chromatin modifications that enhance DNA accessibility
染色质修饰可增强 DNA 可及性
  • 批准号:
    10718867
  • 财政年份:
    2023
  • 资助金额:
    $ 25.38万
  • 项目类别:
Regulation of the lens transcriptome and chromatin architecture by FOXE3
FOXE3 对晶状体转录组和染色质结构的调节
  • 批准号:
    10546497
  • 财政年份:
    2022
  • 资助金额:
    $ 25.38万
  • 项目类别:
Function of a lens protein betaA3/A1-crystallin in astrocytes
星形胶质细胞中晶状体蛋白 betaA3/A1-晶状体蛋白的功能
  • 批准号:
    10366476
  • 财政年份:
    2022
  • 资助金额:
    $ 25.38万
  • 项目类别:
Regulation of the lens transcriptome and chromatin architecture by FOXE3
FOXE3 对晶状体转录组和染色质结构的调节
  • 批准号:
    10355073
  • 财政年份:
    2022
  • 资助金额:
    $ 25.38万
  • 项目类别:
Exploring Crystallin Deamidation as a Causative Agent of Cataracts
探索晶状体蛋白脱酰胺作用作为白内障的致病因素
  • 批准号:
    10538422
  • 财政年份:
    2022
  • 资助金额:
    $ 25.38万
  • 项目类别:
Rusalatide Acetate (TP508) Mitigation of Genotoxic Radiation Damage in Human Lens Epithelial Cells
醋酸鲁沙拉肽 (TP508) 减轻人晶状体上皮细胞的基因毒性辐射损伤
  • 批准号:
    10704484
  • 财政年份:
    2022
  • 资助金额:
    $ 25.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了